Egolan
FDA Label NDC 75448-023
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Sanrace Biotechnology Co., Ltd. for the product Egolan (NDC 75448-023). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding drug facts, active ingredient, purpose, warnings, directions, other information, inactive ingredients, packaging, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Active Ingredient
Ethyl Alcohol 75%
Purpose
Antiseptic
Warnings
Flammable. Keep away from fire or flame.
For external use only. do not inhale or ingest.
Do not use in, or near the eyes. In case of contact with eyes, rinse thoroughly with water.
Avoid contact with broken skin
Stop use and ask a doctor if irritation or rash develops and persists for more than 72 hours.
Directions
• Wet hands thoroughly with product and allow to dry without wiping.
• For children under 6, use only under adult supervision
• Not recommended for infants
Other Information
• Store below 110°F (43°C)
• May discolor certain fabrics or surfaces
Inactive Ingredients
Water,Glycerin,Propylene Glycol,Triethanolamine,Carbomer,Aloe Vera Gel
Packaging
Image (Egolb01)
* Please review the disclaimer below.
